Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1995-3-30
pubmed:abstractText
Amiodarone possesses multiple pharmacologic properties, including peripheral and coronary vasodilatation, negative inotropy, and negative chronotropic and dromotropic effects. These properties are shared by the group of drugs termed calcium channel blockers. We examined the interaction of amiodarone with receptors for the 1,4-dihydropyridine (DHP) calcium blockers in rat and rabbit myocardial membrane particulates. Amiodarone displaced specifically bound [3H]nitrendipine in both rat and rabbit preparations in a competitive, concentration-dependent manner at a single class of binding sites (Ki approximately 0.27 micxroM). Calcium channel activity was determined pharmacologically in a tissue bath with electrically stimulated rabbit right ventricular strips, KCl-induced aortic ring contraction, and 45Ca2+ uptake in K(+)-depolarized cultured rat cardiomyocytes. Amiodarone completely inhibited myocardial contraction (EC50 = 1.7 microM), completely antagonized depolarization-induced aortic ring contraction (EC50 = 24 nM), and significantly reduced (29% vs. control) 45Ca2+ uptake into cultured cells. The calcium channel blocking effects of amiodarone may contribute significantly to its pharmacologic profile.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0160-2446
pubmed:author
pubmed:issnType
Print
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
707-14
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:7532747-Amiodarone, pubmed-meshheading:7532747-Analysis of Variance, pubmed-meshheading:7532747-Animals, pubmed-meshheading:7532747-Aorta, pubmed-meshheading:7532747-Binding, Competitive, pubmed-meshheading:7532747-Calcium, pubmed-meshheading:7532747-Calcium Channel Blockers, pubmed-meshheading:7532747-Calcium Channels, L-Type, pubmed-meshheading:7532747-Cells, Cultured, pubmed-meshheading:7532747-Dose-Response Relationship, Drug, pubmed-meshheading:7532747-Electric Stimulation, pubmed-meshheading:7532747-Heart, pubmed-meshheading:7532747-Heart Ventricles, pubmed-meshheading:7532747-Male, pubmed-meshheading:7532747-Muscle, Smooth, Vascular, pubmed-meshheading:7532747-Muscle Contraction, pubmed-meshheading:7532747-Muscle Proteins, pubmed-meshheading:7532747-Myocardial Contraction, pubmed-meshheading:7532747-Myocardium, pubmed-meshheading:7532747-Nitrendipine, pubmed-meshheading:7532747-Rabbits, pubmed-meshheading:7532747-Radioligand Assay, pubmed-meshheading:7532747-Rats, pubmed-meshheading:7532747-Rats, Sprague-Dawley, pubmed-meshheading:7532747-Vasodilator Agents
pubmed:year
1994
pubmed:articleTitle
Antiarrhythmic agent amiodarone possesses calcium channel blocker properties.
pubmed:affiliation
Department of Veterans Affairs Medical Center, Stanford University School of Medicine, Palo Alto, California 94304.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't